NCT03235401 - The PAH Disability and Bothersomeness Questionnaire | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

June 16, 2017

Primary Completion Date

December 16, 2017

Study Completion Date

February 28, 2018

Conditions

Pulmonary Arterial Hypertension (PAH)

Interventions

OTHER

37-items questionnaire

Patient will answer the PAH-DBoQ questionnaire

Trial Locations (1)

RECRUITING

Centre de Référence de l'Hypertension Pulmonaire Sévère, Service de Pneumologie et Soins Intensifs, Hôpital de Bicêtre,, Le Kremlin-Bicêtre